Acquired immunodeficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:310050
Who is this for?
Show terms as
32Active trials174Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acquired immunodeficiency refers to a group of conditions where the immune system becomes weakened not because of an inherited genetic problem, but because of something that happens during a person's life. Unlike primary (inborn) immunodeficiencies, acquired immunodeficiency develops after birth due to external causes. The most well-known form is AIDS (Acquired Immunodeficiency Syndrome), caused by HIV infection, but there are many other causes including certain medications (such as chemotherapy or immunosuppressive drugs used after organ transplants), cancers that affect the immune system (like lymphoma or leukemia), chronic diseases (such as diabetes or kidney failure), malnutrition, and aging. When the immune system is weakened, the body has trouble fighting off infections and certain cancers. People with acquired immunodeficiency may experience frequent, severe, or unusual infections that healthy individuals would normally fight off easily. These can include repeated pneumonia, persistent fungal infections, chronic diarrhea, and skin infections. Treatment depends on the underlying cause. For HIV/AIDS, antiretroviral therapy has transformed the disease into a manageable chronic condition for many people. For drug-induced immunodeficiency, adjusting medications may help. Supportive care includes preventing infections through vaccines, prophylactic antibiotics, and careful hygiene practices. Immunoglobulin replacement therapy may be used in some cases to boost the immune system.

Key symptoms:

Frequent or recurring infectionsInfections that are unusually severe or hard to treatPersistent feversUnexplained weight lossChronic diarrheaRecurring pneumonia or lung infectionsPersistent oral thrush (white patches in the mouth)Skin infections or rashes that keep coming backSwollen lymph nodesFatigue and weaknessNight sweatsSlow wound healingUnusual cancers such as Kaposi sarcoma or certain lymphomasRecurrent cold sores or shingles outbreaks

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
May 2027Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida

Florida State University — NA

TrialNOT YET RECRUITING
Feb 2027Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partners in Uganda.

San Diego State University — NA

TrialNOT YET RECRUITING
Sep 2026Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

AIDS Malignancy Consortium — PHASE3

TrialNOT YET RECRUITING
Jul 2026Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System

University of Florida

TrialNOT YET RECRUITING
Jun 2026Harmonized Healing: Personalized Music Interventions to Address Chronic Pain in People Living With HIV

Brigham and Women's Hospital — NA

TrialNOT YET RECRUITING
Mar 2026REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

CAN Community Health — PHASE4

TrialNOT YET RECRUITING
Mar 2026Resilient HIV Implementation Science With SGM Youths Using Evidence

University of Maryland, Baltimore — NA

TrialNOT YET RECRUITING
Mar 2026Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Fred Hutchinson Cancer Center — NA

TrialNOT YET RECRUITING
Feb 2026The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

Indiana University — NA

TrialNOT YET RECRUITING
Feb 2026Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Pomeranian Medical University Szczecin

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acquired immunodeficiency.

20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

20 recruitingView all trials with filters →
Phase 44 trials
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Phase 4
Active
PI: Sheldon Morris, MD (UC San Diego AntiViral Research Center (AVRC)) · Sites: San Diego, California · Age: 1899 yrs
Drug-Drug Interaction Study in Trans Women Living With HIV
Phase 4
Active
PI: Mona Loutfy, MD, MPH (Maple Leaf Research) · Sites: Toronto, Ontario · Age: 1899 yrs
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
Phase 4
Active
PI: Ruanne Barnabas, MBChB, MSc, DPhil (Massachusetts General Hospital) · Sites: Gaborone; Kigali, Kigali +1 more · Age: 1699 yrs
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Phase 4
Actively Recruiting
PI: Trana Hussaini, Pharm D (University of British Columbia) · Sites: Vancouver, British Columbia · Age: 1899 yrs
Phase 22 trials
An Integrated Intervention Using a Pill Ingestible Sensor System
Phase 2
Actively Recruiting
· Sites: Los Angeles, California · Age: 1899 yrs
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Phase 2
Active
PI: Jaimie Meyer, MD, MS, FACP (Yale University) · Sites: New Haven, Connecticut · Age: 1899 yrs
Phase 11 trial
A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted
Phase 1
Enrolling by Invitation
PI: Godelieve de Bree (Amsterdam UMC, location VUmc) · Sites: Amsterdam · Age: 1851 yrs
N/A5 trials
Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM
N/A
Actively Recruiting
PI: Michael E Newcomb, Ph.D (Northwestern University) · Sites: Chicago, Illinois · Age: 1634 yrs
Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru
N/A
Active
PI: Alexander J Lankowski, MD (Fred Hutchinson Cancer Center) · Sites: Lima, Lima Province; Lima, Lima Province · Age: 1899 yrs
B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV
N/A
Actively Recruiting
PI: Heather Jaspan, MD PHD (Seattle Children's Hospital) · Sites: Cape Town · Age: 050 yrs
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
N/A
Actively Recruiting
PI: Lunthita M Duthely, Ed.D. (University of Miami) · Sites: Miami, Florida · Age: 1899 yrs
Video-Intervention to Inspire Treatment Adherence for Life for Adolescents
N/A
Actively Recruiting
PI: Saeed Ahmed, MD, MSc (Baylor College of Medicine, Houston Texas) · Sites: Balaka; Balaka +30 more · Age: 1099 yrs
Other5 trials
Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies
Actively Recruiting
· Sites: Guangzhou, Guangdong · Age: 1865 yrs
Nonalcoholic Fatty Liver Disease in HIV Database
Active
PI: Tinsay A Woreta, MD, MPH (Johns Hopkins University) · Sites: Birmingham, Alabama; San Diego, California +6 more · Age: 1899 yrs
The DC Cohort Longitudinal HIV Status Neutral Study
Actively Recruiting
PI: Amanda D Castel, MD, MPH (George Washington University) · Sites: Washington D.C., District of Columbia; Washington D.C., District of Columbia +12 more
Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.
Active
PI: Bruce Ritchie, MD (University of Alberta) · Sites: Edmonton, Alberta · Age: 1899 yrs
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Actively Recruiting
PI: Michael C Sneller, M.D. (National Institute of Allergy and Infectious Disea) · Sites: Bethesda, Maryland · Age: 1899 yrs

Specialists

Showing 25 of 174View all specialists →
LP
Linos Vandekerckhove, MD PhD
Specialist
PI on 2 active trials
SP
Souleymane Mboup, MD; PhD
Specialist
PI on 2 active trials
GM
Guillaume Monneret
Specialist
1 Acquired immunodeficiency publication
SF
Simon Finfer
Specialist
1 Acquired immunodeficiency publication
AD
Adelaide Duku
Specialist
1 Acquired immunodeficiency publication
FR
Fathima Rawther
Specialist
1 Acquired immunodeficiency publication
SS
Sarah C Sasson
BROOKLYN, NY
Specialist
1 Acquired immunodeficiency publication
FV
Fabienne Venet
Specialist
1 Acquired immunodeficiency publication
JD
Julie Demaret
Specialist
1 Acquired immunodeficiency publication
RH
Richard S Hotchkiss
SAINT LOUIS, MO
Specialist
1 Acquired immunodeficiency publication
MA
Mohamed Hassan Ahmed
Specialist
1 Acquired immunodeficiency publication
MG
Morgane Gossez
Specialist
1 Acquired immunodeficiency publication
SB
Sophie Bondje
Specialist
1 Acquired immunodeficiency publication
RJ
Riyah Jiwan
Specialist
1 Acquired immunodeficiency publication
BV
Balasubramanian Venkatesh
Specialist
1 Acquired immunodeficiency publication
HM
Helen McShane
Specialist
PI on 13 active trials2 Acquired immunodeficiency publications
IM
Irini Sereti, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
TM
Timothy Schacker, MD
MINNEAPOLIS, MN
Specialist
PI on 4 active trials
MM
Michael J Vinikoor, MD
CHAPEL HILL, NC
Specialist
PI on 4 active trials
EM
Elaine Abrams, MD
NEW YORK, NY
Specialist
PI on 2 active trials
RP
Robert C. Kaplan, PhD
Specialist
PI on 1 active trial
DM
David Parenti, MD
WYOMISSING, PA
Specialist
PI on 2 active trials
EM
Elaine J Abrams, MD
NEW YORK, NY
Specialist
PI on 2 active trials
EU
Eduardo Vinicius Grego Uemura
Specialist
1 Acquired immunodeficiency publication
JP
Juliet Iwelunmor, PhD
Yaba, Lagos
Specialist

Rare Disease Specialist

PI on 3 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acquired immunodeficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acquired immunodeficiencyForum →

No community posts yet. Be the first to share your experience with Acquired immunodeficiency.

Start the conversation →

Latest news about Acquired immunodeficiency

Disease timeline:

New recruiting trial: Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Strategies to AchieVe Viral Suppression for Youth With HIV

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: The Trans-Led Care Study

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Cefixime Clinical Trial

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: The Eswatini PRISM Study on Adolescents Living With HIV

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Video-Intervention to Inspire Treatment Adherence for Life for Adolescents

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: The DC Cohort Longitudinal HIV Status Neutral Study

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

A new clinical trial is recruiting patients for Acquired immunodeficiency

New recruiting trial: Tools to Identify People At Risk or Already Infected with HIV and HCV

A new clinical trial is recruiting patients for Acquired immunodeficiency

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the specific cause of my immunodeficiency, and can it be reversed?,What infections am I most at risk for, and how can I prevent them?,Do I need prophylactic antibiotics or antifungal medications?,Are there any vaccines I should receive or avoid?,How often do I need blood tests to monitor my immune system?,What symptoms should prompt me to seek emergency care immediately?,Are there any lifestyle changes, dietary adjustments, or supplements that could help support my immune system?

Common questions about Acquired immunodeficiency

What is Acquired immunodeficiency?

Acquired immunodeficiency refers to a group of conditions where the immune system becomes weakened not because of an inherited genetic problem, but because of something that happens during a person's life. Unlike primary (inborn) immunodeficiencies, acquired immunodeficiency develops after birth due to external causes. The most well-known form is AIDS (Acquired Immunodeficiency Syndrome), caused by HIV infection, but there are many other causes including certain medications (such as chemotherapy or immunosuppressive drugs used after organ transplants), cancers that affect the immune system (li

How is Acquired immunodeficiency inherited?

Acquired immunodeficiency follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Acquired immunodeficiency?

Yes — 20 recruiting clinical trials are currently listed for Acquired immunodeficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Acquired immunodeficiency?

25 specialists and care centers treating Acquired immunodeficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.